BridgeBio Oncology Therapeutics, Inc. (BBOT) stock
BBOTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.35−0.21 (-8.20%)
Close on Nov 12, 2026Market cap $188.41MP/E –Yield –
BridgeBio Oncology Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
BridgeBio Oncology Therapeutics's enterprise value was -$139.01M on Nov 11, 2026, against $506.61M a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$139.01M | -126.6% |
| 2025 | Dec 31, 2025 | $523.24M | – |
See a number that looks wrong?